Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights

NAD+ metabolism. NAD+synthesis happens through the kynurenine (de novo) pathway, Preiss-Handler pathway, and NAD+ salvage pathway. In the kynurenine pathway, Tryptophan enters through receptors SLC7A5 and SLC36A4 and is changed into formylkynurenine, then kynurenine, and finally, kynurenic acid or 3-HK. These final compounds are further modified to 3-HAA. Subsequent modifications of 3-HAA into ACMS, quinolinic acid, NAMN, and NAAD lead to final NAD+synthesis via NADS. In the Preiss-Handler pathway, NA is transported via SLC5A8 and SLC22A13 and is converted to NAMN. NR is brought into the cell and is modified into NMN, which is then ultimately converted to NAD+ by NMNAT1-3. Lastly, the salvage pathway recycles NAM produced by the NAD+-consuming pathway into NMN, which is ultimately converted into NAD+. Ectoenzymes CD38 and CD157 convert NAD+into NAM, which enters the cell and is converted into NMN. Lastly, NMN is dephosphorylated by CD73 into NR. Figure created using BioRender.com.
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights

Publication

Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. (2023) Ashita Jain, et al. Front Cardiovasc Med. 2023;10:1212174. Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates SLC7A5 SLC7A5 ncbigene_symbol SLC7A5 8140
Homo sapiens Primates SLC36A4 SLC36A4 ncbigene_symbol SLC36A4 120103
Homo sapiens Primates ACMSD ACMSD ncbigene_symbol ACMSD 130013
Homo sapiens Primates TDO TDO ncbigene_synonym DLX3 1747
Homo sapiens Primates TDO TDO ncbigene_synonym TDO2 6999
Homo sapiens Primates IDO/TDO IDO ncbigene_synonym IDO1 3620
Homo sapiens Primates KMO KMO ncbigene_symbol KMO 8564
Homo sapiens Primates KYNU KYNU ncbigene_symbol KYNU 8942
Homo sapiens Primates 3HAO 3HAO ncbigene_synonym HAAO 23498
Homo sapiens Primates SLC5A8 SLC5A8 ncbigene_symbol SLC5A8 160728
Homo sapiens Primates SLC22A3 SLC22A3 ncbigene_symbol SLC22A3 6581
Homo sapiens Primates QPRT QPRT ncbigene_symbol QPRT 23475
Homo sapiens Primates NAPRT NAPRT ncbigene_symbol NAPRT 93100
Homo sapiens Primates NMNAT1-3 NMNAT2 ncbigene_symbol NMNAT2 23057
Homo sapiens Primates NMNAT1-3 NMNAT1 ncbigene_symbol NMNAT1 64802
Homo sapiens Primates NMNAT1-3 NMNAT3 ncbigene_symbol NMNAT3 349565
Homo sapiens Primates NADPH NADPH ncbigene_synonym DECR1 1666
Homo sapiens Primates NADK NADK ncbigene_symbol NADK 65220
Homo sapiens Primates NRK NRK ncbigene_symbol NRK 203447
Homo sapiens Primates NRK1-2 NRK1 ncbigene_synonym NMRK1 54981
Homo sapiens Primates NRK1-2 NRK2 ncbigene_synonym NEK4 6787
Homo sapiens Primates NRK1-2 NRK2 ncbigene_synonym NMRK2 27231
Homo sapiens Primates ¡NAMPT NAMPT ncbigene_symbol NAMPT 10135
Homo sapiens Primates SLC12A8 SLC12A8 ncbigene_symbol SLC12A8 84561
Homo sapiens Primates NAM NAM ncbigene_synonym STAC3 246329
Homo sapiens Primates CD38, CD38 ncbigene_symbol CD38 952
Homo sapiens Primates CD157 CD157 ncbigene_synonym BST1 683

Chemical mentions

Word Match MeSH Name ChEBI
Quinaldic NA mesh:C008898
Kynurenine NA mesh:C029366
Tryptophan NA
Trp NA mesh:C509690
N-Formylkynurenine Nitrogen mesh:D009584 dinitrogen chebi:17997
KYNU NA
Quinolinic NA mesh:D017378
Nicotinic Acid NA mesh:D009539
NAD NAD mesh:D009243 NAD(+) chebi:15846
NAMN NA
NAAD Nicotinamide arabinoside adenine dinucleotide mesh:C053851 nicotinamide arabinoside adenine dinucleotide chebi:180596
NADS NA mesh:C055737
NADP NA mesh:D009249
NADPH NA mesh:D009249
NADK NA
Nicotinamide Niacinamide mesh:D009536 nicotinamide chebi:17154
riboside acadesine mesh:C011651 acadesine chebi:28498
NMN NA mesh:C070650
NAMPT NA mesh:C085455

Disease mentions

Word Match MeSH Name DOID